BACKGROUNDPrimary liver cancer is the sixth most prevalent tumor and the third leading cause of cancer-relatedmortality worldwide[1]. In 2020, there were approximately 900,000 new cases of primary liver cancer and830,...BACKGROUNDPrimary liver cancer is the sixth most prevalent tumor and the third leading cause of cancer-relatedmortality worldwide[1]. In 2020, there were approximately 900,000 new cases of primary liver cancer and830,000 associated deaths globally, with China accounting for nearly half of these cases. Hepatocellularcarcinoma (HCC) is the most common pathological type of primary liver cancer, accounting for about 90%of primary liver cancer cases in China. Over recent years, the five-year overall survival rate followinghepatectomy for resectable liver cancer has surpassed 60.0%. However, postoperative recurrence remains asignificant concern, particularly among patients classified as stage IIb and IIIa according to the China LiverCancer staging system (CNLC) in China. The one-year recurrence rates for these patients exceed 55%, whilethose with stage Ib and IIa experience recurrence rates of 32.4% and 45.7%, respectively[2].展开更多
文摘BACKGROUNDPrimary liver cancer is the sixth most prevalent tumor and the third leading cause of cancer-relatedmortality worldwide[1]. In 2020, there were approximately 900,000 new cases of primary liver cancer and830,000 associated deaths globally, with China accounting for nearly half of these cases. Hepatocellularcarcinoma (HCC) is the most common pathological type of primary liver cancer, accounting for about 90%of primary liver cancer cases in China. Over recent years, the five-year overall survival rate followinghepatectomy for resectable liver cancer has surpassed 60.0%. However, postoperative recurrence remains asignificant concern, particularly among patients classified as stage IIb and IIIa according to the China LiverCancer staging system (CNLC) in China. The one-year recurrence rates for these patients exceed 55%, whilethose with stage Ib and IIa experience recurrence rates of 32.4% and 45.7%, respectively[2].
